Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008450HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS10034714HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS20027526HPVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44009999HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44012786HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44033742HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44000630HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TCGA Plot Options
Drug Information
GeneCHRNA7
DrugBank IDDB01043
Drug NameMemantine
Target IDBE0002341
UniProt IDP36544
Regulation Typeantagonist
PubMed IDs15522999; 14645141; 22408449
CitationsAracava Y, Pereira EF, Maelicke A, Albuquerque EX: Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. J Pharmacol Exp Ther. 2005 Mar;312(3):1195-205. Epub 2004 Nov 2.@@Maskell PD, Speder P, Newberry NR, Bermudez I: Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. Br J Pharmacol. 2003 Dec;140(7):1313-9. doi: 10.1038/sj.bjp.0705559.@@Pohanka M: Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. Int J Mol Sci. 2012;13(2):2219-38. doi: 10.3390/ijms13022219. Epub 2012 Feb 17.
GroupsApproved; Investigational
Direct ClassificationMonoalkylamines
SMILESCC12CC3CC(C)(C1)CC(N)(C3)C2
Pathways
PharmGKBPA10364
ChEMBLCHEMBL807